AIM Rule 26

The following information is disclosed in accordance with Rule 26 of the AIM Rules for Companies.

Company Key Facts

Last update
11 February 2019
Stock Code
AVO
Year end
31st December
Number of shares in issue
194,566,092
Country of Incorporation
England and Wales
Main countries of Operation
England and Wales, United States, Switzerland
Registered address
Level 17, Dashwood House, 69 Old Broad Street, London EC2M 1QS
Company number
05564418
Date of IPO
4th August 2006 (Listing / Admission to trading)
Shares not in public hands
58.4% 
Index Market
AIM

Details of Any Other Exchanges or Trading Platforms: the Company is not listed on any other exchanges or trading platforms and no such application or agreement has been made for its shares to be so admitted or traded.

Advanced Oncotherapy plc is subject to the UK City Code on Takeovers and Mergers.

To find out further information as required by AIM Rule 26 click on the links below; this will direct users to the relevant areas within the avoplc.com website:

Company Information

Documentations and Announcements

Investor Relations
Investor News Alert Service

Subscribe to our investor alert service and receive all press releases as soon as they become available. Please enter your email address in the box below. You will receive an email confirming your registration.

This Email Alert service is provided by Walbrook PR on behalf of AVO. AVO and Walbrook PR respect your privacy. We promise not to share, rent or sell the information we collect from you, outside of making it periodically available to AVO. Your data is stored securely.